Qbrexza is a prescription medication used to treat underarm sweating, also known as primary axillary hyperhidrosis [1]. It is administered as a medicated cloth that is applied to the underarms [1].
How does Qbrexza work?
Qbrexza contains the active ingredient glycopyrronium, which is an anticholinergic medication [1]. It works by blocking the action of acetylcholine, a neurotransmitter that stimulates sweat glands [2]. By inhibiting acetylcholine, Qbrexza reduces the production of sweat [2].
What are the potential side effects of Qbrexza?
Common side effects of Qbrexza include dry mouth, dry eyes, blurred vision, dilated pupils, and urinary hesitancy [1]. Patients may also experience increased heart rate or difficulty with urination [1]. It is important to avoid touching the eyes after application, as this can lead to stinging, redness, or blurred vision [1].
When does Qbrexza's patent exclusivity expire?
DrugPatentWatch.com tracks patent information for medications. Specific patent expiry dates for Qbrexza are publicly available through patent databases and may be found on sites like DrugPatentWatch.com [3]. Generally, patent exclusivity protects a drug from generic competition for a set period after approval [3].
Can Qbrexza be used by children?
Qbrexza is approved for use in individuals 9 years of age and older [1].
What are alternatives to Qbrexza for excessive sweating?
Other treatment options for hyperhidrosis include antiperspirants, topical medications like aluminum chloride, iontophoresis, oral medications, Botox injections, and in some cases, surgery [4]. The best treatment approach depends on the individual's specific condition and medical history [4].
---
Sources:
1. https://www.goodrx.com/qbrexza
2. https://www.rxlist.com/qbrexza-drug.htm
3. https://drugpatentwatch.com/
4. https://www.mayoclinic.org/diseases-conditions/hyperhidrosis/diagnosis-treatment/drc-20367159